YOLFTbeta
03

Mgenplus Co. Ltd.

032790 · KQ · Healthcare / Biotechnology

1,004.00KRW-24.00 (-2.33%)

Price History

Full chart

Market Stats

Previous Close1,028.00
Open1,059.00
Day Range982.00 – 1,061.00
52-Week Range797.00 – 2,550.00
Volume87.82K
Market Cap32.56B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.42
50-Day Avg1,123.24
200-Day Avg1,509.33

About

Mgen Solutions Co., Ltd. engages in broadband communication network construction business. The company offers electricity, bio business and fire facility construction business, firefighting equipment and construction; printer developer; manufacturing and supply of electrical and electronic products such as transformers and inductors; artificial intelligence video analysis solution; printer developer; communication network for broadcasting communication services; and medical devices. The company was formerly known as Bngt Co.,Ltd. Mgen Solutions Co., Ltd. is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • Employees90
  • Headquarters1117, 2nd Kolon Science Valley, Seoul, South Korea, 06688, Korea
  • Websitehttps://www.mgensolutions.kr/

Financials

Income Statement

Currency: KRW2006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue157.52B135.90B142.64B71.40B63.93B89.71B73.81B58.60B51.29B53.68B49.62B109.79B20.70B34.47B28.59B
Growth (%)--13.73%+4.96%-49.94%-10.47%+40.33%-17.73%-20.60%-12.47%+4.66%-7.57%+121.26%-81.15%+66.56%-17.05%
Cost of Revenue149.67B129.73B137.43B66.25B60.57B80.56B62.51B53.81B47.10B49.68B47.47B96.60B15.71B24.18B24.21B
Gross Profit------9.72B4.79B4.20B4.01B2.15B13.19B4.98B10.29B4.38B
Gross Margin------13.16%8.18%8.18%7.47%4.34%12.01%24.08%29.86%15.31%
Operating Expense------9.31B8.88B5.51B4.15B7.78B10.28B9.87B15.54B14.65B
Operating Income2.31B-----410.90M-4.08B-1.32B-144.55M-5.63B2.91B-4.89B-5.25B-10.27B
Operating Margin1.47%-----0.56%-6.96%-2.57%-0.27%-11.34%2.65%-23.61%-15.23%-35.93%
EBITDA-----------3.06B-16.01B2.10B-9.06B
EBITDA Margin-----------2.79%-77.34%6.11%-31.69%
Net Income2.20B------5.50B-10.30B-5.92B-2.24B-5.76B-435.39M-21.26B3.09B-16.28B
Net Income Margin1.40%------7.45%-17.58%-11.54%-4.17%-11.61%-0.40%-102.72%8.97%-56.95%
R&D---677.41M-813.95M323.27M607.09M608.53M166.69M553.05M1.03B985.74M4.03B1.85B
R&D as % of Total Revenue---0.95%-0.91%0.44%1.04%1.19%0.31%1.11%0.94%4.76%11.70%6.48%
Interest Expense00000000000555.11M478.50M2.49B2.56B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.51%2.31%7.23%8.95%

Balance Sheet

Currency: KRW2006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets44.44B42.74B45.14B47.37B49.76B41.10B32.14B27.26B29.43B35.99B52.08B75.96B67.29B71.42B59.85B
Total Liabilities23.01B25.37B27.36B18.55B30.97B26.98B22.00B18.67B17.96B13.45B33.70B29.47B30.30B27.30B26.16B
Total Equity21.42B17.38B17.78B28.21B16.97B13.80B10.50B8.60B11.49B22.54B18.38B46.48B37.37B44.17B33.78B
Cash1.18B731.29M5.81B4.36B1.06B3.94B2.99B10.68B7.06B3.28B16.49B5.90B18.19B12.05B13.05B
Net Debt--------------1.33B

Cash Flow

Currency: KRW2006-12-312007-12-312008-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-745.57M7.43B--1.24B1.23B-3.28B-1.70B-6.36B-2.49B1.25B-2.07B-5.98B-2.78B
Investing Cash Flow--4.48B4.05B-2.07B-2.09B1.85B-9.09B-5.72B-8.91B----
Financing Cash Flow-3.98B--1.13B--163.49M8.99B7.17B8.61B24.18B----
Capital Expenditure01.42B1.39B637.57M353.60M477.53M795.47M1.38B11.41B2.54B4.06B1.25B10.33B8.74B2.07B
Free Cash Flow------------628.01K-12.40B-14.72B-4.86B
Dividends Paid---3.33M-----------
FCF to OCF------------0.05%598.90%246.29%174.39%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------------
EPS Actual-29198.07-3500.22-1852.76-3471.24387.99602.54-192.39-2886.98573.86318.13-51.23-276.85-887.39-535.67-2442.53119.31-250.6447.06-1622.1128.10-53.83-502.10-788.7847.63-1586.89-571.21-202.02-147.24-303.63-139.367.98-30.4922.49-293.92-389.06133.81-559.8974.97-731.14-664.479.06-741.25-186.88-99.16-81.54-308.54-23.62-16.02361.76174.16-14.45190.8128.39-215.36-61.78-97.02-42.16-1127.51-104.99-32.485.18288.53-115.32-195.43-155.77-239.21-139.33-98.15
Surprise--------------------------------------------------------------------
Timing--------------------------------------------------------------------

Key Statistics & Ratios

Market Cap32.56B
Enterprise Value36.70B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.64
Price / Book1.13
Revenue (TTM)19.88B
Gross Profit (TTM)2.02B
EBITDA-8.82B
Profit Margin-77.60%
Operating Margin-59.64%
Return on Equity-47.99%
Return on Assets-15.09%
Shares Outstanding25.68M
Shares Float20.25M
Beta-0.42
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 27, 20261:2
  • Nov 8, 20239666:9049
  • Jan 9, 20151:5
  • Dec 29, 20091609:1478
  • Aug 21, 20091:5
  • Jun 25, 20041:10